Change - Announcement of Cessation::Cessation of Mr Ang Kok Huan as Chief Executive Officer and Re-designation as Executive Director
Issuer & Securities
JCG INVESTMENT HOLDINGS LTD.
JCG INVESTMENT HOLDINGS LTD. - SGXE87511171 - VFP
JCG W201029 - SGXN50015746 - W4QW
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Cessation of Mr Ang Kok Huan as Chief Executive Officer and Re-designation as Executive Director
Submitted By (Co./ Ind. Name)
Tan Swee Gek
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, Stamford Corporate Services Pte. Ltd. (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Vanessa Ng (Telephone: +65 6389 3065 and Email: firstname.lastname@example.org).
Name Of Person
Ang Kok Huan
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Following the appointment of Dato' Ng Tian Sang @ Ng Kek Chuan as Chief Executive Officer of JCG Investment Holdings Ltd. (the "Company"), Mr Ang Kok Huan will be relinquishing the role of Chief Executive Officer and redesignated to Executive Director of the Company. The redesignation will allow Mr Ang Kok Huan to devote greater attention and focus on regional markets development.
Based on its enquiries, the Company's sponsor, Stamford Corporate Services Pte. Ltd. is satisfied that, other than as disclosed in this announcement, there are no other material reasons for the cessation of Mr Ang Kok Huan as Chief Executive Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer
Role and responsibilities
Mr Ang Kok Huan was responsible for overseeing the overall management of the Group's business. In addition, Mr Ang was tasked with leading the strategic review of the Group's business as well as implementing the future plans of the Group as approved by the Board.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
138,888,889 direct shares
Past (for the last 5 years)
- ANGUS Asset Management Pte Ltd
- ANGUS F&B Pte Ltd
- ANGUS International Holdings Pte Ltd
- Albedo Corporation Pte Ltd
- Brand X Lab Pte Ltd
- JCG Health Pte Ltd
- JCG-Beverly Pte Ltd
- China iMyth Company Pte Ltd
- iMyth Taiwan Limited
- CMIC Hemodialysis Pte Ltd
- CMIC Hemodialysis (Hong Kong) Limited
- Beverly Wilshire Medical Centre Sdn Bhd
- Beverly Wilshire Medical Centre (JB) Sdn Bhd
- Beverly Wilshire Tropicana City Mall Sdn Bhd
- Beverly Wilshire Medical Academy and Research Centre Sdn Bhd
- Beverly Wilshire Cosmetic Surgery Centre Sdn Bhd
- Beverly Wilshire Hair Transplant Sdn Bhd
- Beverly Medical Centre Sdn Bhd
- Natasha Beverly Sdn Bhd
- Beverly Ipoh Sdn Bhd
- Spinalive Beverly Sdn Bhd